How Does Moderna Measure up to Bigger Rival Pfizer?
Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) both began commercializing their coronavirus vaccines in December. Together, they've fully vaccinated about 38% of the U.S. population since that time. In this Motley Fool Live video recorded on May 28, 2021, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss Moderna's work so far in producing and delivering its vaccine -- and how it compares with its biggest rival.
Source Fool.com
